MedPath

The new diagnosis method using nanobecon for colitis associated carcinoma

Not Applicable
Conditions
lcerative colitis Colon carcinoma
Registration Number
JPRN-UMIN000015493
Lead Sponsor
Department of Gastroenterology and Hepatology, Kyoto Univeristy Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with severe ulcerative colitis 2.Patients concomitant with severe infection, heart failure, hepatic disorder, pulmonary disease, or CNS disease 3.Pregnant woman 4.Patients who did not agree with this study 5.Patients that physician determined inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The efficacy of new diagnosis method using nanobecon for colitis associated carcinoma
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath